scispace - formally typeset
Open AccessJournal ArticleDOI

Malignant tumors of nerve sheath origin

John Q. Trojanowski, +2 more
- 01 Sep 1980 - 
- Vol. 46, Iss: 5, pp 1202-1212
Reads0
Chats0
TLDR
Criteria were developed for establishing the nerve sheath origin and malignancy of a given neoplasm which allowed a secure diagnosis of malignant nerve she Heath tumor to be made in 11 of the 24 cases, and 7 cases were of uncertain histogenesis.
Abstract
A clinicopathologic study of malignant nerve sheath tumors diagnosed between 1962 and 1979 at the Massachusetts General Hospital was undertaken. During this 17-year period, 24 patients with such a neoplasm were seen while 607 patients were treated for schwannoma or neurofibroma. Criteria were developed for establishing the nerve sheath origin and malignancy of a given neoplasm which allowed a secure diagnosis of malignant nerve sheath tumor to be made in 11 of the 24 cases. In 7 of the remaining cases, the malignant tumors were of uncertain histogenesis and in 6 cases, a new diagnosis was made. The malignant tumors constituted 2% of all neoplasms of the nerve sheath origin diagnosed during this period. An attempt was made to grade these neoplasms, but clinical and histologic parameters were only approximately predictive of their behavior. The treatment and survival or the 11 patients with malignant nerve sheath tumors and the 7 with malignant neoplasms of uncertain histogenesis are detailed and compared. In the former group, 4 patients died within four and a half years and there were eight recurrences in 4 patients. In the latter group, 4 died within three and a half years and there were five recurrences in 3 patients.

read more

Citations
More filters
Journal ArticleDOI

Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases.

TL;DR: Overall, 63% of the patients died of tumor; large tumor size and high mitotic rate portended a poor prognosis, as did the need for resection by amputation, and an unexpected finding was the absence of a significant difference in survival rates between patients with and without VRN.
Journal ArticleDOI

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1

TL;DR: It is suggested that the choice of treatment for MPNST should be independent of NF1 status, as in studies published in the last decade, survival in the 2 patient groups has been converging, as especially the NF1 group has shown improved prognosis.
Journal ArticleDOI

Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases.

TL;DR: Only 4% of malignant peripheral nerve sheath tumors (MPNST) show perineurial cell differentiation, and the prognosis of perineural MPNST appears to be more favorable than that of conventional MPN ST.
Journal ArticleDOI

Tumors of the peripheral nervous system.

TL;DR: Patients with von Recklinghausen's disease had almost as good a 10-year survival rate as those with solitary malignant schwannoma, and of 100 patients with malignant neurilemmomas treated by the author, 74 were considered determinate; among them, the 10- year "cure" rate was 32%.
Journal ArticleDOI

Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis.

TL;DR: Patients with MPNST have a poor prognosis with a high risk for local and distant failures (> 50%), but patients with neurofibromatosis type 1 have a highrisk for developing a second MPN ST.
References
More filters
Journal ArticleDOI

Malignant schwannoma. A Clinicopathologic Study

TL;DR: During the period from 1920‐1970, 902 patients with a tumor of the peripheral nervous system were treated at the Memorial Sloan‐Kettering Cancer Center, and Histologic review of this material revealed 115 cases which fulfilled strict criteria for clinicopathologic diagnosis of malignant schwannoma.
Journal ArticleDOI

Solitary malignant schwannoma.

Related Papers (5)